<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T2" position="float">
 <label>TABLE 2</label>
 <caption>
  <p>Zika vaccines in clinical trials.</p>
 </caption>
 <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
  <thead>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>Name</bold>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>Vaccine type</bold>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>Immunogen</bold>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>Developers</bold>
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <bold>Current status</bold>
    </td>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">VRC5283</td>
    <td valign="top" align="left" rowspan="1" colspan="1">DNA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Wild type prM and E genes, needle-free injection</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NIAID</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Phase II</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">GLS-5700</td>
    <td valign="top" align="left" rowspan="1" colspan="1">DNA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Consensus prM and E genes, injection &amp; electroporation</td>
    <td valign="top" align="left" rowspan="1" colspan="1">GeneOne life science Inc./Inovio Pharmaceuticals</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Phase I</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">ZIKV purified inactivated vaccine (ZPIV)</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inactivated vaccine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Formalin-inactivated whole virus</td>
    <td valign="top" align="left" rowspan="1" colspan="1">WRAIR/NIAID/Harvard University/Sanofi Pasteur</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Phase I</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">VLA1601</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Inactivated vaccine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Formalin-inactivated whole virus</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Valneva Australia GmbH</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Phase I</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">rZIKV/D4delta30</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Chimeric live attenuated vaccine</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ZIKV prM and E genes inserted to DEN4delta30</td>
    <td valign="top" align="left" rowspan="1" colspan="1">NIAID</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Phase I</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">MV-ZIKA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Viral vector</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ZIKV prM and E genges inserted to measles virus vector</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Themis Bioscience GmbH</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Phase I</td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">mRNA-1325</td>
    <td valign="top" align="left" rowspan="1" colspan="1">mRNA</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Lipid nanoparticle encapsulated modified mRNA of prM and E</td>
    <td valign="top" align="left" rowspan="1" colspan="1">ModernaTX, Inc.</td>
    <td valign="top" align="left" rowspan="1" colspan="1">Phase I</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
